The production of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex several-stage synthetic process. Early routes focused on peptide portion coupling, utilizing solid-phase https://dawudsiwk193258.blognody.com/49253533/creation-and-investigation-implementations-of-retatrutide